Glucagon Like Peptide 1 Analogs Is Estimated To Witness High Growth Owing To Increasing Prevalence Of Diabetes
Glucagon-like peptide 1 (GLP-1) analogs are injectable drugs used to treat type 2 diabetes. They work by stimulating the release of insulin from the pancreas, suppressing glucagon secretion, and slowing gastric emptying which leads to a reduction in post-prandial glycemia. GLP-1 analogs such as Exenatide and Liraglutide are prescribed as an adjunct to diet and exercise to improve glycemic...
0 Comments 0 Shares 1249 Views 0 Reviews
Sponsored